CTSD enhances the proliferation and invasiveness of NSCLC cells [27] CTSD was validated in a clinical study and could acts as a biomarker for osteosarcomas, pulmonary metastasis, and bone malignancies [28]. The gene discussed is CTSD; the disease is non-small cell lung carcinoma.